Open Source Medicine
Earlier this week I spoke about the growth of industries catering to an ageing population. Biotechnology is one sector that seems disproportionately poised to benefit. With the demographic trend firmly in place, the demand for drugs, combined with the expiration of important drug patents, will act as additional tailwinds behind the